Corporate news

Revenues up 6.2% to EUR 344.0m, 3.1% on organic basis Adjusted EBITDA rises 9.5% to EUR 68.0m Adjusted net income increases by 28.3% to EUR 29.2m…

Centor is the clear market leader in the US prescription plastic vial retail market for oral drugs The deal extends Gerresheimer’s footprint in the…

Revenues up 6.3% to EUR 356.4m (1.9% on an organic basis) Adjusted EBITDA rises 10.6% to EUR 72.1m Net income grows by 7.4% to EUR 22.4m Earnin…

Gerresheimer will sell its borosilicate glass tubing business to Corning Corning and Gerresheimer enter into a 10-year-supply agreement for…

Increase in dividend to EUR 0.75 per share Large majority for resolution approving work of Management Board and Supervisory Board Gerresheimer…

Duesseldorf, April 30, 2015 – At its meeting following today’s Annual General Meeting, the Supervisory Board of Gerresheimer AG elected Dr. Axel…

Revenues up 1.4% to EUR 301.8m (organic growth -2.4%) Adjusted EBITDA growth of 7.2% to EUR 51.0m (Q1 2014: EUR 47.6m) Net income climbs 22.8% to…

Revenues up 1.9% (3.7% organically) to EUR 1,290.0m Adjusted EBITDA totals EUR 258.5m at constant exchange rates Earnings per share up 6.6% to…

Düsseldorf/Dongguan City (People’s Republic of China), October 22, 2014 – Gerresheimer AG, an internationally leading partner to the pharma and…